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Department of Chemistry, University of Nevada, Las Vegas
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Abstract

Results
HT-1080 Cell Migration Assay Using 3μm Pore FluoroBlok
13-Hour Migration Period, Pre-treated +/- 10 μM BeSO4
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Background

Cell Division: A172 Sensitivity to [BeSO4]
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Cell migration is a vital component of metastasis. In this study, our intent
was to study cell migration by alteration of the Wnt/GSK-3 Pathway. Since
BeSO4 is a known GSK-3 kinase inhibitor, we hypothesized that this agent
would cause cell migration to decrease as a result of β-catenin stabilization.
Two human cell lines, HT-1080 (fibrosarcoma) and A172 (glioblastoma),
were used to observe migration levels in the presence and absence of
BeSO4. Our results show that cell migration is diminished for cells that
were pre-treated with BeSO4, in comparison to the untreated (control)
cells.
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In order for a cell to migrate, during metastasis or under other conditions,
cell-cell contacts must be broken, and cell-substrate contacts (i.e. focal
adhesions) must be formed to give the moving cell traction. An enzyme
known as GSK-3 kinase regulates the function of a bi-functional protein
called β-catenin. In the cytoplasm, β-catenin serves as a key structural
component of adherens junction, the points of contact between
neighboring cells. These cell-cell contacts contain transmembrane
cadherins that link to dynamic membrane and cytoskeletal substructures,
of which β-catenin is a key constituent. Under normal conditions, GSK-3
kinase phosphorylates β-catenin, which then undergoes ubiquitindependent proteolysis. However, using a GSK-3 kinase inhibitor, such as
BeSO4, would allow for the stabilization of β-catenin, and thus potentially
increase cell-cell adhesion and decrease cell migration.
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Figure 1a. Low micromolar BeSO4 inhibits cell proliferation in glioblastoma
cells. A172 cells were dosed with BeSO4 on Day 0 and counted after 9 days
with 1:4 splits every 3 days.
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Figure 3a. HT-1080
cells were
pretreated with +/BeSO4 for 36 hours.
Plates were
approximately 8085% confluent. A
wound was made
at t=0 (using a
pipette tip) and cell
migration was
observed at t=0,
t=3, t=6, and t=9 hr.
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Methods
•Coulter Counter
• Used to count cells in order to assess effects on cell division.
• BeSO4 is known to affect cell division in many cell types, but its effect on
HT-1080 cells has never been studied.
•In Vitro FluoroBlok Tumor Cell Migration Assay
• BeSO4 treated and untreated cells were allowed to migrate from the
apical surface to the basal surface through the membrane via 3 μm
pores. Cells that had migrated to the basal surface were stained with a
fluorescent dye and mean fluorescence was measured to determine cell
migration.
•Wound-Healing Assay
• A pipette tip was used to make an initial wound (cell-free area), which
was then monitored over time to observe the amount of cell migration.
1.

Grow cells to preferred confluence in +/BeSO4 media.
2. Use a pipette tip to scrape away cells in a
line across the dish.
3. Observe cell migration back into the
cleared area.
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Figure 1b. Low micromolar BeSO4 inhibits cell proliferation in fibrosarcoma
cells. HT-1080 cells were dosed with BeSO4 on Day 0 and counted after 8 days
with 1:8 splits every 2 days.
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Figure 2a. Untreated and 10μM BeSO4 (3-days pre-treated) HT-1080 cells were
allowed to pass through 3μm pores within the membrane via cell migration. Cells
that had migrated to the basal side of the membrane were stained with a
fluorescent dye, and the mean fluorescence was measured to quantify cell
migration. Cells were seeded into the migration assay chambers at higher density
(30,000 cells/well) and lower density (15,000 cells/well) to determine the optimal
conditions for the experiment.
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Figure 2 (b & c). Microscopy of basal side
of membrane, showing fluorescentlylabeled cells that had migrated from the
apical side. B) Untreated HT-1080 cells
that had passed through the 3μm pores in
the membrane. C) Pre-treated (3 days)
10μM BeSO4 HT-1080 cells that had
passed through the 3μm pores in the
membrane.

Conclusion
After confirming the sensitivity of A172 and HT-1080 to BeSO4 in the
Proliferation Assay, the FluoroBlok Tumor Cell Migration Assay and the
Wound-Healing Assay demonstrated that both cell lines show a decrease in
cell migration when treated with BeSO4. We hypothesize that BeSO4
treatment causes stabilization of β-catenin, which allows for stronger cellcell contacts, and therefore decreased cell migration. Further studies are
planned to test this hypothesis.
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